Progyny Inc (PGNY)

Return on total capital

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) US$ in thousands 67,455 62,184 23,341 32,340 8,348
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 422,062 553,429 376,968 251,822 166,947
Return on total capital 15.98% 11.24% 6.19% 12.84% 5.00%

December 31, 2024 calculation

Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $67,455K ÷ ($—K + $422,062K)
= 15.98%

Based on the data provided, Progyny Inc's return on total capital has varied over the years. The return on total capital was 5.00% as of December 31, 2020, which increased to 12.84% by December 31, 2021, representing a significant improvement. However, there was a slight decrease in the return on total capital to 6.19% as of December 31, 2022.

Subsequently, the return on total capital experienced another increase to 11.24% by December 31, 2023, and a notable further increase to 15.98% as of December 31, 2024. This upward trend indicates the company's ability to generate higher returns relative to its total capital investment, which is a positive indication of its operational efficiency and profitability.

Overall, the fluctuation in Progyny Inc's return on total capital over the years suggests the company's ongoing efforts to optimize its capital allocation and drive better performance across its operations. It will be important for investors and stakeholders to monitor this metric in conjunction with other financial indicators to assess the company's financial health and sustainability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Return on total capital
Progyny Inc
PGNY
15.98%
DaVita HealthCare Partners Inc
DVA
1,725.93%
Sotera Health Co
SHC
10.37%